English 
لا توجد منتجات في سلة المشتريات.
TAROLIMUS 0.03% 15 GM OINT
74.00 EGP
متوفر في المخزون
| * Indications: Tacrolimus Ointment, for adults, and for children aged 2 to 15 years, is indicated for short-term and |
| & intermittent long-term therapy in the treatment of patients with moderate to severe atopic dermatitis in |
| & whom the use of alternative, conventional therapies are deemed inadvisable because of potential risks, |
| & or in the treatment of patients who are not adequately responsive to or are intolerant of alternative, |
| & conventional therapies. |
| * Dosage and Method of Administration: |
| # Adult: |
| & Apply a thin layer of Tacrolimus Ointment to the affected skin areas twice daily and rub in gently and |
| & completely. Treatment should be continued for one week after clearing of signs and symptoms of atopic |
| & dermatitis. |
| & The safety of Tacrolimus Ointment under occlusion which may promote systemic exposure, has not been |
| & evaluated. Tacrolimus Ointment should not be used with occlusive dressings. |
| # Pediatric: |
| & Apply a thin layer of Tacrolimus Ointment 0.03% to the affected skin areas twice daily and rub in gently |
| & and completely. Treatment should be continued for one week after clearing of signs and symptoms of |
| & atopic dermatitis. he safety of Tacrolimus Ointment under occlusion, which may promote systemic |
| & exposure, has not been evaluated. Tacrolimus Ointment 0.03% should not be used with occlusive |
| & dressings. |
| * Contraindications: |
| & Tacrolimus Ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any |
| & other component of the preparation. |
| * Warnings and precautions: |
| # General: |
| & Studies has not evaluated the safety and efficacy of tacrolimus ointment in the treatment of clinically |
| & infected atopic dermatitis. Before commencing treatment with tacrolimus ointment, clinical infections at |
| & treatment sites should be cleared. |
| & While patients with atopic dermatitis are predisposed to superficial skin infections including eczema |
| & herpeticum (Kaposi’s varicelliform eruption), treatment with Tacrolimus Ointment may be associated with |
| & an increased risk of varicella zoster virus infection (chicken pox or shingles), herpes simplex virus |
| & infection, or eczema herpeticum. In the presence of these infections, the balance of risks and benefits |
| & associated with Tacrolimus Ointment use should be evaluated. |
| & In clinical studies, 33 cases of lymphadenopathy (0.8%) were reported and were usually related to |
| & infections (particularly of the skin) and noted to resolve upon appropriate antibiotic therapy. Of the 33 |
| & cases, the majority had either a clear etiology or were known to resolve. Transplant patients receiving |
| الوزن | 100 kg |
|---|
TACROLIMUS 0.03% (0.3 MG/GM)
منتجات ذات صلة
مستحضر لعلاج الاكزيما والصدفية
60.00 EGP
دواء يؤثرعلي ايض خلايا السرطان
62.50 EGP
بدائل البلازما (محاليل الدم)
4.50 EGP
مضادات الفطريات
15.60 EGP